- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
CollPlant Biotechnologies (NASDAQ:CLGN), Quotes and News Summary
CollPlant Biotechnologies (NASDAQ: CLGN)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-18 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.140 | -0.320 | -0.1800 | ||||
| REV | 2.740M | 66.000K | -2.674M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
CollPlant Biotechnologies Questions & Answers
You can purchase shares of CollPlant Biotechnologies (NASDAQ: CLGN) through any online brokerage.
Other companies in CollPlant Biotechnologies’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
The latest price target for CollPlant Biotechnologies (NASDAQ: CLGN) was reported by HC Wainwright & Co. on Tuesday, February 9, 2021. The analyst firm set a price target for 26.00 expecting CLGN to rise to within 12 months (a possible 209.89% upside). 0 analyst firms have reported ratings in the last year.
The stock price for CollPlant Biotechnologies (NASDAQ: CLGN) is $8.39 last updated June 24, 2022, 7:59 PM UTC.
There are no upcoming dividends for CollPlant Biotechnologies.
CollPlant Biotechnologies’s Q2 earnings are confirmed for Thursday, August 18, 2022.
There is no upcoming split for CollPlant Biotechnologies.
CollPlant Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.